Skip to main content
SpringerLink
Log in

Pompholyx, a common palmoplantar skin disorder, usually requires a combination of topical and systemic therapy

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Wollina U. Pompholyx: a review of clinical features, differential diagnosis, and management. Am J Clin Dermatol 2010; 11(5): 305–14

    Article  PubMed  Google Scholar 

  2. Champion RH, Burton JL, Ebling FJG, editors. Textbook of Dermatology. 5th ed. Melbourne (VIC): Blackwell Scientific Publications, 1992

    Google Scholar 

  3. Veien NK, Ølholm Larsen P, Thestrup-Pedersen K, et al. Long-term, intermittent treatment of chronic hand eczema with mometasone fuorate. Br J Dermatol 1999; 140(5): 882–6

    Article  PubMed  CAS  Google Scholar 

  4. Harper J. Topical corticosteroids for skin disorders in infants and children. Drugs 1988; 36Suppl. 5: 34–7

    Article  PubMed  Google Scholar 

  5. Schnopp C, Remling R, Möhrenschläger M, et al. Topical tacrolimus (FK 506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 2002; 46(1): 73–7

    Article  PubMed  Google Scholar 

  6. Schurmeyer-Horst F, Luger T, Böhm M. Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema [letter]. Dermatology 2007; 214(1): 99–100

    Article  PubMed  Google Scholar 

  7. Belsito DV, Fowler Jr JF, Marks Jr JG, et al. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Multicenter Investigator Group. Cutis 2004; 73(1): 31–8

    PubMed  Google Scholar 

  8. Hanifin JM, Stevens V, Sheth P, et al. Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br J Dermatol 2004; 105(3): 545–53

    Article  Google Scholar 

  9. Wollina U, Abdel Naser MB. Pharmacotherapy of pompholyx. Expert Opin Pharmacother 2004; 5(7): 1517–22

    Article  PubMed  CAS  Google Scholar 

  10. Boettger MK, Bär KJ, Dohrmann A, et al. Increased vagal modulation in atopic dermatitis. J Dermatol Sci 2009; 53(1): 55–9

    Article  PubMed  CAS  Google Scholar 

  11. Scerri L. Azathioprine in dermatological practice: an overview with special emphasis on its use in non-bullous inflammatory dermatoses. Adv Exp Med Biol 1999; 455: 343–8

    Article  PubMed  CAS  Google Scholar 

  12. Egan CA, Rallis TM, Meadows KP, et al. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 1999; 40(4): 612–4

    Article  PubMed  CAS  Google Scholar 

  13. Pickenacker A, Luger TA, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol 1998; 134(3): 378–9

    Article  PubMed  CAS  Google Scholar 

  14. Reitamo S, Granlund H. Cyclosporin A in the treatment of chronic dermatitis of the hands. Br J Dermatol 1994; 130(1): 75–8

    Article  PubMed  CAS  Google Scholar 

  15. Pigatto PD, Gibelli E, Fumagalli M, et al. Disodium cromoglycate versus diet in the treatment and prevention of nickel-positive pompholyx. Contact Dermatitis 1990; 22(1): 27–31

    Article  PubMed  CAS  Google Scholar 

  16. Wollina U, Karamfilov T. Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison. J Eur Acad Dermatol Venereol 2002; 16(1): 40–2

    Article  PubMed  CAS  Google Scholar 

  17. Swartling C, Naver H, Lindberg M, et al. Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J Am Acad Dermatol 2002; 47(5): 667–71

    Article  PubMed  Google Scholar 

  18. Hunziker T, Haudenschild-Falb E, Schmidli J, et al. “Aqua-SUP” in chronic palmoplantar dermatoses [in German]. Hautarzt 1987; 38(3): 165–7

    PubMed  CAS  Google Scholar 

  19. Douwes KE, Karrer S, Abels C, et al. Does smoking influence the efficacy of bath-PUVA therapy in chronic palmoplantar hand eczema? Photodermatol Photoimmunol Photomed 2000; 16(1): 25–9

    Article  PubMed  CAS  Google Scholar 

  20. Stambaugh MD, DeNittis AS, Wallner PE, et al. Complete remission of refractory dyshidrotic eczema with the use of radiation therapy. Cutis 2000; 65(4): 211–4

    PubMed  CAS  Google Scholar 

  21. Odia S, Vocks E, Rakoski J, et al. Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed current. Acta Derm Venereol 1996; 76(6): 472–4

    PubMed  CAS  Google Scholar 

  22. Wollina U, Uhlemann C, Elstermann D, et al. Therapy of hyperhidrosis with tap water iontophoresis: positive effect on healing time and lack of recurrence in hand-foot eczema [in German]. Hautarzt 1998; 49(2): 109–13

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pompholyx, a common palmoplantar skin disorder, usually requires a combination of topical and systemic therapy. Drugs Ther. Perspect 27, 18–20 (2011). https://doi.org/10.1007/BF03257131

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03257131

Search

Navigation